abstract |
The present invention provides with an oxoisoquinoline derivative represented by the formula (I) (in the formula, Q and Rare as defined in the description) or a pharmaceutically acceptable salt thereof, which is useful as a Bruton's kinase inhibitor for treating cancer, B-cell lymphoma, chronic lymphocytic leukemia and the like. |